Rapper Common joins Allergan to warn in rhyme—and swirling color—about vision loss chelfand Tue, 03/14/2017 – 10:37 More: Rapper Common joins Allergan to warn in rhyme—and swirling color—about vision loss Source: fierce
read morePatients with follicular lymphoma in Scotland have gained a new treatment option for the condition after the Scottish Medicines Consortium (SMC) published advice accepting Roche’s Gazyvaro for routine use by NHS Scotland. On the downside, funding for Shire’s Onivyde to
read moreNovartis’ selective cyclin-dependent kinase inhibitor Kisqali has been approved by the US Food and Drug Administration as a treatment for patients with a certain form of breast cancer. More: US nod for Novartis’ breast cancer drug Kisqali Source: News
read moreVifor Pharma, Celgene, Takeda and Pierre Fabre have been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice thus bringing discredit upon and reducing confidence in the sector. More: Pharma firms fall foul
read morePatients with atopic dermatitis are to get early access to Sanofi’s dupilumab before its marketing authorisation in the UK, after the Medicines and Healthcare Products Regulatory Agency issued a positive scientific opinion for the drug through the country’s Early Access
read moreCEL-SCI More: CEL-SCI Announces That the NYSE MKT Approves Plan Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals